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Background: Given that acne is a rare condition in societies with higher consumption of omega-3 (n-3) relative to
omega-6 (n-6) fatty acids, supplementation with n-3 may suppress inflammatory cytokine production and thereby
reduce acne severity.
Methods: 13 individuals with inflammatory acne were given three grams of fish oil containing 930 mg of EPA to
their unchanged diet and existing acne remedies for 12 weeks. Acne was assessed using an overall severity grading
scale, total inflammatory lesion counts, and colorimetry.
Findings: There was no significant change in acne grading and inflammatory counts at week 12 compared to
baseline. However, there was a broad range of response to the intervention on an individual basis. The results
showed that acne severity improved in 8 individuals, worsened in 4, and remained unchanged in 1. Interestingly,
among the individuals who showed improvement, 7 were classified as having moderate to severe acne at baseline,
while 3 of the 4 whose acne deteriorated were classified as having mild acne.
Conclusion: There is some evidence that fish oil supplementation is associated with an improvement in overall
acne severity, especially for individuals with moderate to severe acne. Divergent responses to fish oil in our pilot
study indicates that dietary and supplemental lipids are worthy of further investigation in acne.
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Acne vulgaris is a common yet complex inflammatory
skin disease in Westernized nations and the overall oc-
currence rate appears to be rising [1,2]. Inflammatory
mediators are predominantly released by activated leu-
kocytes and result in inflammatory acne lesions charac-
terized by pain, redness, and swelling [3]. Given that
acne is a rare condition in non-Westernized societies
with higher ratios of n-3 to n-6 from dietary intake, it
appears that the lower n-3 content of the western diet is
an important dietary modulator of these inflammatory
mediators [1,4-6]. A case control study of Koreans found
that individuals with acne consumed significantly less
fish and more junk food than the control group [7].
A similar study of an Italian population found that
consumption of fish was associated with a protective
effect against moderate to severe acne [8]. This inverse* Correspondence: bburnswhitmo@csupomona.edu; twspalding@
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reproduction in any medium, provided the orassociation between fish consumption and acne sever-
ity is expected because fish contains high levels of n-3
fatty acid eicosapentaenoic acid (EPA) that acts as a
competitive inhibitor of AA conversion to inflammatory
mediators, PGE2 and LTB4, which leads to reduced
inflammatory acne lesions [9]. Some of these mediators
include n-6 eicosanoids, prostaglandin E2 (PGE2), and
leukotrine B4 (LTB4) that are derived from arachidonic
acid (AA), an n-6 polyunsaturated fatty acid. Cytokines
such as interleukin 1B (IL-1B) and tumor necrosis factor
α (TNF-α) are also important inflammatory mediators
[10]. It has also been shown that n-3 fatty acid sup-
plementation suppresses the production of TNF-α and
IL-Iβ in healthy individuals [3,10-12]. Despite the fact
that the anti-inflammatory properties of EPA have been
well-established in the literature, very few human studies
have examined the clinical effects of this n-3 fatty acid
on reducing inflammation in acne patients. A recent
retrospective study examined the effect of a poly-nutrient
supplementation containing EPA and antioxidants onLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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ently used the supplement for 2 months. Inflammatory
acne lesion count was significantly reduced in all patients
[13]. Given that the various studies that supplementation
with antioxidants may help reduce severity of acne, it
would be interesting to investigate whether fish oil can
exert the same effects [14-17]. The objective of this
study was to detect the isolated effects of EPA in the form
of fish oil on severity of inflammatory acne in young
healthy males.
Methods
Healthy males ages 18–40 with mild to severe acne were
recruited and screened to ensure they were not frequent
consumers of n-3 fatty acids and have not received and
are not currently receiving intense acne treatments. Each
participant was required to consume 3 fish oil capsules
daily for 12 weeks that contained a total of 930 mg EPA,
720 mg DHA, and 174 mg DPA per 3 capsules. Partici-
pants continued their usual diets but were required to
complete 4 separate 3-day food diaries throughout the
intervention to ensure they were not consuming large
amounts of additional n-3 rich foods. They also logged
the type of acne cleansers or medication (if any) that
were taken daily. Compliance was measured also by par-
ticipants’ self-reporting. Photos of the face were taken at
baseline, week 6, and 12 with a Canon Rebel XS camera
under the same temperature and lighting. Using these
photos, total inflammatory lesions counts and acne
severity grades were determined using the Allen and
Smith grading scale (Table 1) [18]. In addition, objective
measurements of skin redness were obtained using a
Konica Minolta CR-400 colorimeter using the L*a*b*
color system as defined by the Commission Internation-
ale de L’Eclairage. One control of normal non-inflamed
facial area and two or more acne areas were predeter-
mined and marked on the photos for each participant.
The same areas were measured at baseline, week 6 and
12, each measurement being an average of 3 repeats by
1 observer. Redness is signified by increasing positive
values of a* above 0 and lightness is denoted by increas-
ing values of L* from 0 to 100. We obtained the differ-
ence between the control and acne areas for each
participant as Δ = acne – control.
A total of 16 healthy men were enrolled in this study
and 13 completed the protocol. Two participantsTable 1 Changes in acne grade severity after 12 weeks of
fish-oil supplementation
Acne Grade n (%)
0 2 4 6 8
Before Treatment 1 (7) 4 (30) 2 (15) 2 (15) 4 (30)
After Treatment 2 (15) 5 (38) 2 (15) 3 (23) 1 (7)withdrew from the study and 1 participant was excluded
from the data analysis due to self-reported compliance
of less than 70%. The participants were young and had a
BMI consistent with being normal in weight [19]. Seven
participants (54%) identified their ethnicity as Hispanic/
Latino, 3 as Caucasian (23%), and 3 (23%) as Asian.
The research protocol was approved by the Human
Subjects Committee of the Institutional Review Board at
California State Polytechnic University, Pomona, proto-
col # 10-190.
Findings
A one-tailed Wilcoxon Signed Ranks test did not reveal
a significant difference between Week 0 and Week 12
acne grade, Z (Week 12-Week 0) = −1.044, p > .05. A
total of 8 (62%) participants improved at least one-point
acne grade over the 12 weeks of supplementation. Acne
grade worsened for 4 (31%) participants and did not
change for 1 (7%) individual. Table 1 shows the number
(and percentage) of individuals classified in each acne
grade before and after supplementation. A one-tailed t-
test for dependent means did not reveal a significant
difference in mean acne counts for Week 0 and Week
12, t(12) = 0.338, p > .05. Mean acne count in Week 0
was 30 (SE = 5.06) and 31 (SE = 5.67) in Week 12.
As expected, the unbiased effect size was small, d' = 0.08
(SEd' = 0.26). One-way repeated measures analysis
of variance did not reveal significant difference in
mean Δa* or ΔL* across weeks F(2,24) < 1.0, Huynh-
Feldt ε = 1.000, p > 0.05 (Figure 1).
Even though statistical significance was not obtained
for acne severity and lesion counts, the results of this
study should be interpreted with caution and are likely
inconclusive, for we clearly observed that the change in
overall acne ratings over the 12-week supplementation
period was in the predicted direction. After 12 weeks of





Figure 1 Changes in Δa* and ΔL* throughout 12 weeks of fish-
oil supplementation.
Figure 2 Difference in acne severity changes among individuals with mild vs. moderate-severe acne at baseline.
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baseline. Five of these 8 individuals improved one grade
and the rest improved at least two grades. One partici-
pant’s acne grade shifted from the most severe (grade 8)
to the least severe grade (grade 0). Prior to supplementa-
tion, nearly one-third of the participants (n = 4) had an
acne grade of 8, which is the most severe grade based on
the scale used. All of these individuals had a less severe
acne rating, as indicated by a lower grade at the end of
the study. Of the 5 individuals who did not show im-
provement, acne severity worsened for 4 individuals and
did not change for one individual. Notably, of the 4 indi-
viduals whose acne worsened, 3 individuals had mild
acne (grades 0 or 2) at the start of the study (Figure 2).
The individual whose acne did not change also exhibited
mild acne (rating of 2) at the start of the study. On the
other hand, 7 of the 8 individuals who entered the study
with moderate to severe acne (grades 4, 6, and 8) saw
improvement in acne severity by the end of the study.
This may be the reason why significant results were not
obtained in this study, at least for the acne severity rat-
ings. The sample population included a relatively large
proportion (38.5%) of individuals with mild acne. SinceFigure 3 Participant photo before use of fish-oil supplements
at baseline.their acne grades were already near the low end of the
scale at the start of the study, there was little room for
obvious improvement and conversely greater opportun-
ity for worsening. Similarly, a lack of significant differ-
ence in acne lesion counts between Weeks 0 and 12 may
be partially due to a floor effect; that is, the inclusion of
several individuals who had mild acne at the start of the
study. These findings raise the question of whether the
efficacy of fish oil supplementation is dependent on
the initial acne severity. In other words, perhaps only
individuals with moderate to severe acne can benefit
from fish oil supplementation.
In addition, it should be noted that in counting the in-
flammatory lesions, we did not differentiate between the
types of inflammatory lesions for our data analysis. In
other words, we did not distinguish between papules,
pustules, and cysts in the lesion count, but rather cate-
gorized them all as inflammatory lesions. This may be
why we did not achieve high correlation between a* and
actual inflammatory lesion counts, 0.42, 0.62, and 0.44 at
baseline, week 6, and week 12, respectively. Thus, given
the fact that acne is a dynamic disease, any improvement
in the type of inflammatory lesion might have not beenFigure 4 Participant photo after use of fish-oil supplements at
week 12.
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accurate and reliable results could be obtained if a larger
measuring head were used to obtain the redness and
lightness measurements.
Although non-significant, there was a visible decrease
in mean Δa* at week 6 (Figure 1) which suggest that fish
oil supplementation for 6 weeks is sufficient to reduce
inflammation, because a* is well-understood to be corre-
lated with erythema (increased blood flow to the skin)
[20,21]. The non-significant linear increase in ΔL* from
baseline to week 12 is also consistent with existing stud-
ies that found an inverse relationship between a* and L*
in inflammatory skin diseases [22,23]. However, there
should be more investigation into whether L* correlates
with subjective assessment of different stages of an
acne lesion.
Although we cannot draw any firm conclusions from
our study with a small sample size and no placebo group,
there is some promising evidence that fish oil supplemen-
tation is associated with an improvement in ratings of
overall acne severity, especially for individuals with mod-
erate and severe acne. It is possible that increasing the
dose of EPA from 930 mg to 3–6 grams daily, as recom-
mended for arthritis patients, would reveal more signifi-
cant results [24]. In addition, effects of n-3 fatty acids
should be examined in cohorts of subjects with the same
acne severity grades or lesion counts in order to isolate
the potential effect on different types of acne severity.
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